Federal MS therapy panel flawed: MDs
Tuesday, December 7, 2010 - 18:30
in Health & Medicine
The federal panel that rejected the idea of an immediate clinical trial into an experimental vein procedure for Canadians with multiple sclerosis had several deficiencies that should be remedied in future panels, researchers say.